December 09, 2019 Sanofi goes all in with $2.5bn Synthorx buy The French drugmaker bets big as it plays catch-up in the immuno-oncology space with a next-generation IL-2 buyout.
January 10, 2019 After a bumper year, biotech flotations remain on the cards The buoyant biopharma IPO scene set several new records in 2018, a notable achievement given the stock market turmoil of the fourth quarter.
